Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00346892
Status:
COMPLETED
Last Update Posted:
2016-09-09
First Post:
2006-02-03
Brief Title:
To Evaluate 2 Doses of GSK Biologicals Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV
Sponsor:
Organization:
GlaxoSmithKline